Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: An MR imaging study in 28 patients

American Journal of Neuroradiology

Volumn 32, Issue 3, 2011, Pages 527-531

  Pirker, Agnes ^a   Kramer, L ^b   Voller, B ^a   Loader, B ^a   Auff, E ^a   Prayer, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Krankenhaus Hietzing   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; BRAIN EDEMA; CLINICAL ARTICLE; COLLOID; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOTIC PRESSURE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RISK FACTOR;

BIOLOGICAL MARKERS; BRAIN EDEMA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; STATISTICS AS TOPIC;

EID: 79952790104     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2332     Document Type: Article

References (25)

1. Hinchey J, Chaves C, Appignan B, et al. A reversible posterior encephalopathy syndrome. N Engl J Med 1996;334:494-500
2. Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiological findings. Mayo Clin Proc 2010;85:427-32
3. Mueller-Mang C, Mang T, Pirker A, et al. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiol 2009;51:373-85
4. Doelken M, Lanz S, Rennert J, et al. Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI. Diagn Interv Radiol 2007;13:125-28 (Pubitemid 47354344)
5. Ijima T, Kubota Y, Kuroiwa T, et al. Blood-brain barrier opening following transient reflex sympathetic hypertension. Acta Neurochir Suppl 1994;60:142-44
6. Sheth R, Rigs J, Bodensteiner J, et al. Parietal occipital edema in hypertensive encephalopathy: a pathologic mechanism. Eur Neurol 1996;36:25-28
7. Gocmen R, Ozgen B, Oguz K. Widening the spectrum of PRES: a series from a tertiary care center. Eur J Radiol 2007;62:454-59 (Pubitemid 46783357)
8. Bartynski WS. Posterior reversible encephalopathy syndrome. Part 2. Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043-49. Epub 2008 Apr 10 (Pubitemid 351954864)
9. Weidauer S, Gaa J, Sitzer M, et al. Posterior encephalopathy with vasospasm: MRI and angiography. Neuroradiology 2003;45:869-76 (Pubitemid 38072257)
10. Lewis D, Tooke J, Meaman M, et al. Peripheral microvascular parameters in the nephrotic syndrome. Kidney Int 1998;54:1261-67
11. Quinlan G, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005;41:1211-19 (Pubitemid 40770271)
12. Vande Walle J, Dockerwolcke R. Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 2001;16:283-93 (Pubitemid 32232951)
13. Vogel SM, Minshall RD, Pilipovic M, et al. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol 2001;281:L512-22
14. Chou M, Lai P, Yen L, et al. Posterior reversible encephalopathy syndrome: magnetic resonance imaging and diffusion-weighted imaging in 12 cases. Kaoshiung J Med Sci 2004;20:381-88 (Pubitemid 39279236)
15. Bartynski WS, Boardman J, Zeiger Z, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179-90 (Pubitemid 44788652)
16. Horbinski C, Bartynski WS, Carson-Walter E, et al. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol 2009;30:588-90. Epub 2008 Oct 14
17. Kaysen G. Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin Am Soc Nephrol 2009;4(suppl 1):S56-63
18. Margarson M, Soni N. Serum albumin: touchstone or totem. Anaesthesia 1998;53:789-803
19. Peters T. All About Albumin: Biochemistry, Genetics and Medical Applications. San Diego: Academic Press; 1996
20. Nicholson J, Wolmarans M, Park G. The role of albumin in critical illness. Br J Anaesthes 2000;85:599-610
21. Bito R, Hino S, Baba A, et al. Degradation of oxidative stress induced denatured serum albumin in rat liver endothelial cells. Am J Physiol Cell Physiol 2005;289-91:C531-642. Epub 2005 May 4
22. Fernandez J, Navasa M, Garcia-Pagan JC, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2004;41:384-90 (Pubitemid 39158747)
23. Ishikura K, Ikeda M, Hamasaki Y, et al. Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 2006;48:231-39
24. Sweiss K, Beri R, Shord SS. Encephalopathy after high dose ifosfamide: a retrospective cohort study and review of the literature. Drug Saf 2008;31:989-96
25. Bartynski WS, Boardman J. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:447-55 (Pubitemid 351424055)